Pliant Therapeutics
Price & Volume
Stats
See more52W Range | $1.10-$16.52 |
Market Cap | $97.6M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.47 |
News
See moreYahoo Finance • 12 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
Yahoo Finance • 12 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
Yahoo Finance • 26 days ago
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
Yahoo Finance • last month
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
About
CEO | Dr. Bernard Coulie M.B.A., M.D., Ph.D. |
Address | 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 171 |
